Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1991 5
1992 2
1993 3
1994 1
1996 2
1997 5
1998 4
1999 3
2001 6
2002 7
2003 10
2004 3
2005 11
2006 9
2007 7
2008 8
2009 11
2010 20
2011 24
2012 15
2013 25
2014 28
2015 19
2016 14
2017 22
2018 18
2019 28
2020 33
2021 37
2022 33
2023 36
2024 43
2025 42

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

469 results

Results by year

Filters applied: . Clear all
Page 1
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators. Smith MR, et al. N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8. N Engl J Med. 2018. PMID: 29420164 Free article. Clinical Trial.
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.
Freedland SJ, de Almeida Luz M, De Giorgi U, Gleave M, Gotto GT, Pieczonka CM, Haas GP, Kim CS, Ramirez-Backhaus M, Rannikko A, Tarazi J, Sridharan S, Sugg J, Tang Y, Tutrone RF Jr, Venugopal B, Villers A, Woo HH, Zohren F, Shore ND; EMBARK Study. Freedland SJ, et al. N Engl J Med. 2023 Oct 19;389(16):1453-1465. doi: 10.1056/NEJMoa2303974. N Engl J Med. 2023. PMID: 37851874 Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.
Loriot Y, Necchi A, Park SH, Garcia-Donas J, Huddart R, Burgess E, Fleming M, Rezazadeh A, Mellado B, Varlamov S, Joshi M, Duran I, Tagawa ST, Zakharia Y, Zhong B, Stuyckens K, Santiago-Walker A, De Porre P, O'Hagan A, Avadhani A, Siefker-Radtke AO; BLC2001 Study Group. Loriot Y, et al. N Engl J Med. 2019 Jul 25;381(4):338-348. doi: 10.1056/NEJMoa1817323. N Engl J Med. 2019. PMID: 31340094 Clinical Trial.
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.
Sternberg CN, Fizazi K, Saad F, Shore ND, De Giorgi U, Penson DF, Ferreira U, Efstathiou E, Madziarska K, Kolinsky MP, Cubero DIG, Noerby B, Zohren F, Lin X, Modelska K, Sugg J, Steinberg J, Hussain M; PROSPER Investigators. Sternberg CN, et al. N Engl J Med. 2020 Jun 4;382(23):2197-2206. doi: 10.1056/NEJMoa2003892. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469184 Clinical Trial.
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Powles T, van der Heijden MS, Castellano D, Galsky MD, Loriot Y, Petrylak DP, Ogawa O, Park SH, Lee JL, De Giorgi U, Bögemann M, Bamias A, Eigl BJ, Gurney H, Mukherjee SD, Fradet Y, Skoneczna I, Tsiatas M, Novikov A, Suárez C, Fay AP, Duran I, Necchi A, Wildsmith S, He P, Angra N, Gupta AK, Levin W, Bellmunt J; DANUBE study investigators. Powles T, et al. Lancet Oncol. 2020 Dec;21(12):1574-1588. doi: 10.1016/S1470-2045(20)30541-6. Epub 2020 Sep 21. Lancet Oncol. 2020. PMID: 32971005 Clinical Trial.
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies.
Yang HC, Kwok PY, Li LH, Liu YM, Jong YJ, Lee KY, Wang DW, Tsai MF, Yang JH, Chen CH, Yeh EC, Wei CY, Fann CS, Huang YT, Chen CW, Lee YJ, Chu SK, Ho CH, Yang CS, Lee YL, Chen HH, Hou MC, Chiou JF, Yang SF, Wang CH, Huang CY, Chiu KM, Chen M, Chiang FT, Lee SL, Chen SS, Yao WJ, Chien CC, Lin SY, Chang FP, Ho HL, Yeh YC, Tseng WC, Lin MH, Chang HT, Tseng LM, Liang WY, Chen PC, Hang JF, Lin SC, Chan YJ, Kuo YJ, Wang LC, Pan CC, Hsieh YC, Chen YM, Hsiao TH, Lin CH, Chen YJ, Chen IC, Mao CL, Chang SJ, Chang YL, Liao YJ, Lai CH, Lee WJ, Tung H, Yen TT, Yen HC, Shih CM, Chou TY, Liou TH, Chiang CY, Cherng YG, Chen CH, Chiu CH, Tseng SH, Lin EP, Chen YJ, Chuang HP, Chen TC, Huang WT, Sin J, Liu IL, Chen YC, Chao KK, Wu YM, Yu PP, Chang LP, Yen KY, Chang LC, Sheen YJ, Chen YT, Kan K, Tsai HL, Wang YK, Hou MF, Yang YH, Kuo CH, Wu WJ, Huang JF, Chong IW, Tsai JR, Lin CY, Yu MC, Lee TH, Tsai MH, Ou YC, Chen PY, Hu TH, Shyu YC, Cheng CK, Fang YJ, Hsieh SC, Chen CH, Chen CC, Li KJ, Lin CH, Chiu HY, Wu CC, Chen CY, Chu SJ, Liu FC, Yang FC, Chang HA, Chen WL, Yang SS, Sung YF, Wang TF, Lin SZ, Wu YW, Wu CS, Jiang JY, Ma GC, Chang TY, Hwang JJ, Kao KJ, Hung CF, Chiu TF, Chen PY, Tsui K, Wu … See abstract for full author list ➔ Yang HC, et al. Among authors: ou yc. Nature. 2025 Dec;648(8092):117-127. doi: 10.1038/s41586-025-09680-x. Epub 2025 Oct 15. Nature. 2025. PMID: 41092961 Free PMC article.
Cancer Immunoimaging with Smart Nanoparticles.
Ou YC, Wen X, Bardhan R. Ou YC, et al. Trends Biotechnol. 2020 Apr;38(4):388-403. doi: 10.1016/j.tibtech.2019.11.001. Epub 2019 Dec 5. Trends Biotechnol. 2020. PMID: 31812371 Review.
469 results